Cases


  • All
  • Antitrust Litigation
  • Consumer Protection Litigation
  • Securities Litigation
  • Shareholder Derivative Litigation
  • Shareholder Merger Litigation
  • Employment Litigation
  • Pharmaceutical Litigation
  • Personal Injury Litigation

12 Nov 2015

In re Lamictal Direct Purchaser Antitrust Litig., No. 12-00995 (D.N.J.)

In the Lamictal case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of SmithKline Beacham's Lamictal, prescription drugs used to treat epilepsy, bipolar disorder and other medical conditions. The class ...

Joseph T. Lukens, Peter Kohn at New York office

Read more

05 Apr 2013

In re Niaspan Antitrust Litig., No. 13-cv-1820 (E.D. Pa.)

In the Niaspan case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Abbott Laboratories' triglyceride drug, Niaspan, whose active ingredient is niacin (vitamin B6). Faruqi & Faruqi filed the first direct ...

Joseph T. Lukens, Peter Kohn at Pennsylvania office

Read more

05 Mar 2013

In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litig., No. 13-cv-2445 (E.D. Pa.)

In the Suboxone case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a class of direct purchasers of Reckitt Benckiser's opioid addiction drug, Suboxone. The class alleges that Reckitt took several actions to suppress competition from generic ...

Joseph T. Lukens, Peter Kohn at Pennsylvania office

Read more

16 Dec 2011

In re Lipitor Antitrust Litigation, No. 12-2389 (PGS/DEA) (D.N.J.)

In this case, nicknamed Lipitor, Faruqi & Faruqi, LLP represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Pfizer's branded blockbuster cholesterol drug Lipitor (atorvastatin calcium), and direct purchasers of generic Lipitor ...

Joseph T. Lukens, Peter Kohn at Pennsylvania office

Read more

14 Dec 2011

In re Effexor XR Antitrust Litigation, No. 11-cv-5479 (D.N.J.)

In the Effexor XR case, Faruqi & Faruqi, LLP represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Wyeth's (now Pfizer's) branded antidepressant drug Effexor XR (extended-release venlafaxine hydrochloride capsules). The class ...

Joseph T. Lukens, Peter Kohn at Pennsylvania office

Read more

03 Feb 2009

In re AndroGel Antitrust Litigation (II), 09-md-2084 (N.D. Ga.)

In the Androgel litigation, Faruqi & Faruqi, LLP represent a pharmaceutical wholesaler and a proposed class of direct purchasers of Abbott's branded testosterone drug, AndroGel. The case alleges that Abbott's predecessor filed baseless patent litigation ...

Joseph T. Lukens, Peter Kohn at Pennsylvania office

Read more

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania